We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our
cookie policy
.
OK
Company-detail.com
Home
Terms
Contact
list of NY corporations
What to Know About Leqembi, the Alzheimer’s Drug Approved by the FDA
Medicare will cover much of the cost for patients in the early stages of the disease, but Leqembi has safety risks and can only modestly slow cognitive decline.
read more
Source: NY Times
00:20, July 7, 2023
Pam Belluck
You may also like
John Kerry to Visit China to Restart Climate Negotiations
00:38, July 7, 2023
Lisa Friedman
U.S. and China, by the Numbers
08:13, July 7, 2023
Ana Swanson
Gen X Is in Charge. Don’t Make a Big Deal About It.
11:00, July 7, 2023
Emma Goldberg
Fed Rate Increases Hinge on Strength of Jobs and Economy
12:07, July 7, 2023
Jeanna Smialek
Why a Strong Jobs Report Could Rattle the Stock Market
13:56, July 7, 2023
Andrew Ross Sorkin, Ravi Mattu, Bernhard Warner, Michael J. de la Merced, Lauren Hirsch and Ephrat Livni
Tips for Canceling Online Subscriptions
15:00, July 7, 2023
Ann Carrns
F.B.I. Searched the Home of Kraken’s Jesse Powell
00:14, July 7, 2023
David Yaffe-Bellany and Ryan Mac
Threads Becomes Most Rapidly Downloaded App as Twitter Threatens Meta
23:40, July 6, 2023
Mike Isaac
FDA Makes Alzheimer’s Drug Leqembi Widely Accessible
23:26, July 6, 2023
Pam Belluck
Heat Records Broken Across Earth
22:33, July 6, 2023
Brad Plumer and Elena Shao
Mike Cavanagh, NBCUniversal’s New Leader, Overhauls Top Ranks
21:53, July 6, 2023
Benjamin Mullin and Nicole Sperling
Nations Aim to Zero Out Shipping Emissions by Midcentury
21:18, July 6, 2023
Max Bearak
News
Crafting a Haggis for American Tastes (and Import Restrictions)
23:32, January 25, 2025
Remy Tumin
38 Injured After ‘Unexpected Aircraft Movement’ on a United Flight
22:31, January 25, 2025
Lauren McCarthy
Amazon’s Fight With Unions Heads to Whole Foods Market
19:34, January 25, 2025
Danielle Kaye